Evaluation of Children with Malignancies for Blood and Marrow Transplantation: A Report from the ASTCT Committee on Practice Guidelines
Ellen Fraint, Hisham Abdel‐Azim, Neel S. Bhatt, Larisa Broglie, Asma Chattha, Mira A. Kohorst, Yiouli P. Ktena, Michelle A. Lee, Susan E. Long, Muna Qayed, Akshay Sharma, Heather E. Stefanski, Anant Vatsayan, Lisa Wray, Mehdi Hamadani, Paul A. Carpenter
Abstract
Evaluation of a candidate for hematopoietic cell transplantation (HCT) is a complex process with substantial intercenter variability. Although literature providing guidance for evaluating the eligibility of adults is well established, similar guidance for children is lacking. To address gaps between adult recommendations and the specific needs of children, we convened a panel of pediatric HCT experts from a wide geographic range of American Society of Transplantation and Cellular Therapy (ASTCT) member institutions to offer recommendations for pediatric-focused pre-HCT evaluation. In this report from the ASTCT Committee on Practice Guidelines, we present a practical framework for evaluating children with malignancies who are candidates for HCT. We also highlight key differences from adults and emphasize areas of unmet need that require additional research to delineate best practices.